Abstract
Glioblastoma is the most common adult brain tumor and one of the deadliest human malignancies. The reason for this dark scenario, which has not changed significantly in the last 3 decades, is inherent to the biological properties of glioblastoma. Therefore, it is urgent to understand its molecular players in order to develop novel and targeted therapeutic strategies. KIT, a member of the …